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Introduction
The endoplasmic reticulum luminal protein torsinA, encoded by TOR1A, is a widely expressed member of the large AAA + family of adenosine triphosphatases (ATPases) (Ozelius et al., 1997; Konakova et al., 2001) . AAA + proteins participate in a diverse range of cellular activities, including protein chaperone activities, membrane trafficking, organelle biogenesis and powering cellular proteins (Neuwald et al., 1999; Vale, 2000) .
Mutations in TOR1A cause torsion dystonia-1 (MIM: 128100) (also known as DYT1 dystonia), an autosomal dominant disease with incomplete penetrance (Ozelius and Lubarr, 1993; Ozelius et al., 1997) . Dystonia is a neurological movement disorder characterized by repetitive and sustained involuntary muscle contractions resulting in severe twisting movements and abnormal postures involving one or more sites of the body (Ozelius and Lubarr, 1993) . DYT1 dystonia, the most common and severe genetic form of primary or isolated (Albanese et al., 2013) dystonia, is an early-onset generalized dystonia, presenting in childhood and involving much of the body (Ozelius and Lubarr, 1993) . Severity of symptoms and distribution vary widely between affected individuals, ranging from mild focal dystonia to severe generalized dystonia. The highest prevalence of DYT1 dystonia has been identified in the Ashkenazi-Jewish population (Zeman and Dyken, 1967; Eldridge, 1970; Korczyn et al., 1980) . Most cases of DYT1 dystonia identified so far are caused by a heterozygous in-frame trinucleotide deletion (c.907_909delGAG), resulting in the loss of a glutamic acid residue (p.Glu303del) in the C-terminus of the torsinA protein, close to the ATP binding region (Ozelius et al., 1989 (Ozelius et al., , 1997 (Ozelius et al., , 1999 Ozelius and Lubarr, 1993; Bressman et al., 2002) . This 3-bp deletion appears to have arisen separately in different ethnic populations. Additional TOR1A variations have been described in isolated patients including in-frame deletions as well as missense variants however their clinical significance is unknown (Leung et al., 2001; Zirn et al., 2008; Calakos et al., 2010; Cheng et al., 2014; Vulinovic et al., 2014; Dobricic et al., 2015) .
One intriguing aspect of DYT1 dystonia associated with the p.Glu303del mutation is that it displays greatly decreased penetrance, with only one-third of the individuals harbouring the GAG deletion manifesting the disease before the age of 28 years (Bressman et al., , 2002 Risch et al., 1995) . The full basis of the variable penetrance caused by the p.Glu303del mutation in early-onset torsion dystonia is still unknown. However, the presence of possible genetic modifiers of the torsinA pathway has been suggested as factors that modulate p.Glu303del phenotypes (Risch et al., 2007) . It is known that another variant in TOR1A (p.Asp216His, rs1801968), when found in trans configuration with the p.Glu303del variant, protects individuals from manifesting the disease (Risch et al., 2007) .
As part of on-going studies into arthrogryposis, next generation sequencing (NGS) was applied in 25 genetically-unresolved cases with a clinical presentation of arthrogryposis multiplex congenita (AMC), which is defined as congenital contractures in more than two joints and in multiple body areas (Hall, 1997) . In three families, NGS revealed homozygous variations in TOR1A. The previously known p.Glu303del in TOR1A associated with DYT1 dystonia was found in a homozygous state in two unrelated families with severe arthrogryposis, developmental delay, strabismus and tremor. In addition, a novel homozygous missense variant in TOR1A (c.952G4A, p.Gly318Ser) was detected in two affected siblings of one additional family with a similar presentation of severe arthrogryposis, developmental delay, strabismus and tremor.
Materials and methods

Ethical approval
The study was approved by the ethical standards of the relevant institutional review board, the Ethics Review Committee in the Gothenburg Region (Dn1: 842-14), the KariminejadNajmabadi Pathology and Genetics ethics committee, and the Human Research Ethics Committee of the University of Western Australia. Informed consent was obtained from all parents included in this study after appropriate genetic counselling. Blood samples were obtained from patients and their parents. The parents in this study provided written informed consent to publish their family trees, and family data, including photographs.
Clinical evaluation
Twenty-five cases of AMC with congenital contractures in more than two joints and in multiple body areas were collected through international collaboration with a number of clinical and genetics centres over the past 5 years. Medical history, physical examination and imaging were performed as part of routine clinical work-up. For the four TOR1A mutation-positive patients, extensive clinical follow-up was performed.
Genetic analysis
Next-generation sequencing (whole exome and/or targeted neuromuscular panel sequencing) was performed on patient DNA. Bidirectional Sanger sequencing was performed in the patients and their unaffected parents. Detailed methods are provided in the Supplementary material.
Cell assay
The c.952G4A (p.Gly318Ser) mutation, was introduced by QuikChange Õ II (Agilent Technologies) into the human fulllength wild-type TOR1A cDNA fragment (GenScript). Human embryonic kidney 293 (HEK 293) cells were transfected with wild-type or mutant torsinA fused to enhanced green fluorescent protein (EGFP), using Lipofectamine 2000 TM .
Results
Clinical characteristics of patients
The 25 AMC cases all had the core phenotype of congenital contractures in more than two joints and in multiple body areas. Additional features were present in some of the cases (Supplementary Table 1 ).
Family 1
Case 1 is a 2-month-old male, the first child of an apparently healthy first cousin couple (Fig. 1) . Pregnancy was uneventful. Delivery was by Caesarean section at term because of long delivery and foetal distress. He was examined at 2 months of age. He had strabismus, deep-set eyes, short upturned nose, wide mouth, large ears, low and posteriorlyrotated ears, wrinkled skin, flexion of wrist, flexion of wrist, clenched hand, camptodactyly, rocker-bottom feet and hammer toes. Other phenotypic features are listed in Table 1 . The parents described tremor in the hands and feet that improved over time and completely resolved by 18 months of age. However, he developed stereotypic hand movement and facial grimacing when agitated, which may be dystonic but it is not conclusive (Supplementary Video 1). The hand movements occur about two or three times daily. There is also neck extension, which improves with sleep. This may suggest a type of cervical dystonia. The joint contractures had considerably improved and he could extend and open his elbows, knees, wrists and hands, which were not possible in infancy. However, he was severely delayed and could not sit, walk or say any words. Strabismus became worse over time. Case 2, a male aged 2 years 3 months, is the second affected offspring of this family. Delivery was by Caesarean section at term. Birthweight, length and head circumference as well as other features are listed in Table 1 . He had flexion contracture of all joints, including elbows, wrists, fingers, hips, knees, ankles and toes. He developed strabismus from 10 months of age, which became worse as he grew older. Similar to his older brother, he had tremor in his limbs from birth until he was 18 months of age. About the same time that he no longer had tremor, he started having stereotypic hand gestures when agitated (Supplementary Video 1). The hand movement occurs two to three times daily, the same as his older brother. He also had severe psychomotor delay. He could not sit, walk or say any words. Both siblings have increased muscle tone involving axial and proximal limb muscles causing a permanent adduction of the arms and hyperextension of the neck that does not disappear during sleep but it does improve.
Family 2
Case 3, a female, is the first and only child of healthy first cousin parents (Fig. 1) . Pregnancy and delivery were uneventful. Birthweight, length and head circumference along with other features are listed in Table 1 . Examination at 8 days of age showed prominent occiput, short neck, low-set ears, flexion contracture at the elbows and knees, bilateral hip dislocation, hammer toes, ulnar deviation of wrists, clenched hands, and overlapping fingers. She had very little movement, but tremor in hands and feet. At follow-up at 2 years and 7 months of age, she could not talk, walk or sit. She had just achieved the ability to roll over. The flexion contracture in the elbows and wrists and clenched hands had significantly improved and she could extend her elbows and open her hand. However, strabismus had developed. The contractures in her knees had improved but she could not yet fully extend her knees. She had increased muscle tone. There was still limited movement in the ankles and toes. She understood simple commands such as clap hands and responded. Her measurements at 2 years and 7 months of age are listed in Table 1 . MRI evaluation of brain was normal.
Family 3
Case 4, a female, is the first and only child of first cousin parents (Fig. 1) . Pregnancy was uneventful; delivery by Caesarean section at term was elective. Birth measurements and other features are listed in Table 1 . She was hospitalized for 2 days after birth because of respiratory difficulty. She had retrognathia, upslanting palpebral fissures, ptosis, high palate, contractures in most joints, could not fully extend elbows, kyphoscoliosis, umbilical hernia, limited movement of knee, almost no flexion in knees, clubfeet, prominent heel and tremor in the thighs. EMG/nerve conduction velocity was normal. Karyotype was normal. Brain MRI was normal (Fig. 2) . Re-examination at 2 years and 5 months of age revealed that she was 53rd centile for height, weight and head circumference (Table 1) . She developed intermittent strabismus, which became worse, in the sense that the degree of esotropia had increased during the intervals of strabismus (Table 1) . She had achieved the ability to roll over at 24 months, and crawl at 26 months, but she was not able to walk yet. Muscle tone was increased. She said her first words at 18 months of age and at 2 years and 5 months of age had a vocabulary of 10 words.
Genetic findings
Data from whole exome sequencing on DNA from Families 1 and 3 were analysed through the use of the Ingenuity Variant Analysis (IVA) software (Qiagen, Hilden, Germany). The filtering strategy of initially concentrating on homozygous coding variants in known neurogenetic disease genes suggested the same candidate gene in the two families. A novel homozygous missense mutation in exon 5 of TOR1A (c.952G4A), leading to substitution of a highly conserved glycine to serine (p.Gly318Ser), was identified in Case 1 (Family 1). The common 3-bp deletion in TOR1A (exon 5, c.907_909delGAG, p.Glu303del), associated with dominant TOR1A dystonia in the heterozygous state, was identified in the homozygous state in Case 4 (Family 3). Targeted sequencing of 336 known neurogenetic disease genes (Supplementary material) in DNA from Case 3 (the proband of Family 2) identified the TOR1A c.907_909delGAG (p.Glu303del) in the homozygous state. The TOR1A variants were validated by PCR and bidirectional Sanger sequencing analysis, which also identified homozygosity for the TOR1A c.952G4A, (p.Gly318Ser) in Case 2, the affected sibling of Case 1 in Family 1 (Fig. 3) . The asymptomatic parents in Families 1-3 were each heterozygous for the variants. The p.Glu303del is present on 30 of 282 658 alleles and the p.G318S is not present on any allele in the Genome Aggregation Database (gnomAD). None of the remaining 21 AMC cases had any rare sequence variants in TOR1A.
Another variant in TOR1A (p.Asp216His, rs1801968), when found in the trans configuration with the p.Glu303del, protects individuals from manifesting the disease (Risch et al., 2007) . Thus, exon 4 harbouring p.Asp216 was additionally sequenced in patients and their parents to study whether the lack of clinical symptoms in the parents could be explained by this single nucleotide polymorphism in trans. None of the parents or patients were carriers of the p.Asp216His polymorphism.
Status of confirmed carriers
Co-segregation studies confirmed that all parents in Families 1-3 were carriers of TOR1A variants. Given that the recurrent p.Glu303del and other identified variants in TOR1A are associated with a dominant disease with reduced penetrance (DYT1 dystonia), all carrier parents were examined by an experienced neurologist. They showed no evidence of neurological symptoms or signs. The parents in Families 1-3 had 13, eight and 15 siblings, respectively. None of the siblings of the parents showed dystonia or any form of movement disorder by history.
Cell assays
Wild-type torsinA is predominantly localized in the endoplasmic reticulum. To assess the translocation of mutated torsinA into the nuclear envelope, cultured cells were transfected with wild-type and mutant torsinA EGFP constructs and the subcellular localization was investigated. The p.Gly318Ser torsinA variant was abnormally concentrated in the nuclear envelope, as has been reported previously for the disease-associated p.Glu303del and p.Phe205Ile substitutions (Goodchild and Dauer, 2004; Calakos et al., 2010) . In addition, the p.Gly318Ser torsinA variant caused spheroid bodies in the vast majority of the transfected cells (Fig. 4B) , as seen in cells transfected with p.Glu303del and p.Phe205Ile mutants (Goodchild and Dauer, 2004; Calakos et al., 2010) . Spheroid bodies were not seen in cells transfected with wild-type torsinA EGFP (Fig. 4) .
Discussion
The heterozygous loss of the p.Glu303 glutamic acid residue in the carboxyl terminus of the torsinA protein leads to DYT1 dystonia, a neurodevelopmental disorder characterized by early-onset generalized dystonia. DYT1 dystonia associated with p.Glu303del is characterized by incomplete penetrance, and variable expressivity, whereby family members carrying the mutation have profound differences in their clinical courses. Only 30% of mutation carriers exhibit abnormal movements (Ozelius and Lubarr, 1993) . It is unknown why disease penetrance and expressivity is so variable between individuals carrying the identical c.907_909delGAG, p.Glu303del mutation. However, 2-deoxyglucose studies have shown abnormal brain metabolism in all carriers (Eidelberg, 1998; Eidelberg et al., 1998; Trost et al., 2002) . Likewise, all DYT1 dystonia p.Glu303del mutation carriers assessed by neuroimaging showed white matter abnormalities associated with reduced integrity of the cerebellothalamocortical motor pathway (Argyelan et al., 2009; Niethammer et al., 2011) . The data from these studies indicate that ascertainment of the actual penetrance of clinical phenotype in TOR1A mutation carriers requires accurate assessment of the phenotype.
Homozygous Tor1a p.Glu303del mutation causes 100% mortality of mice within 48 h after birth (Cookson and Clarimon, 2005; Dang et al., 2005; . To elucidate the basic mechanisms leading to disease, compared the phenotypes of mice with a torsinA knock-out or a knock-in p.Glu303del mutation. Homozygous torsinA knock-out mice as well as homozygous knock-in mice with two copies of the p.Glu303del allele died shortly after birth, suggesting that torsinA is indispensable for development. In addition, mice with a single p.Glu303del allele on a knock-out background showed the same phenotype. Thus, p.Glu303del fails to rescue the lethality of the knock-out model . Taken together, these results indicated that the p.Glu303del mutant allele behaves as a loss-of-function allele and that the mutant torsinA causes the disease through a loss of function/haploinsufficiency.
In the current study, only the four cases from the three unrelated families with TOR1A variants had the unique combination of arthrogryposis multiplex congenita, development delay, strabismus and tremor. Two probands are homozygous for the well-known TOR1A p.Glu303del mutation, two siblings are homozygous for a novel (p.Gly3018Ser) variant. The TOR1A patients showed severe contractures of large and small joints including the elbows, wrists, fingers, knees, ankles and toes, which improved with age. Congenital hip dislocation was seen in two of four patients. Interestingly, the strabismus gets worse with age in all four patients. Developmental delay and intellectual disability were present in all patients; however, the degree of delay was variable. Case 1 and his younger brother (Case 2) were severely delayed and they have not developed the ability to speak or communicate verbally. Case 3 could not speak at the age of 2 years and 7 months but had started to communicate non-verbally with the parents and had started to make sounds (Table 1) . Case 1 and 2 showed stereotypic hand movements when agitated. They developed these hand movements from the age of 18 months. Case 1 also showed facial grimacing, which in addition to the hand posturing, could be dystonic but this was not conclusive. There was also forced neck extension, which improved mildly with sleep, which is suggestive for retrocollis, a type of cervical dystonia. All TOR1A cases had increased muscle tone. Umbilical hernia and wrinkled skin were each seen in only one TOR1A patient and could be unrelated to the condition. All TOR1A patients are still very young and follow-ups are necessary. Additional patients are required to fully evaluate the association of these clinical features with homozygous TOR1A disease. Our finding is, however, further corroborated by a recent study and an abstract reporting association of arthrogryposis with the TOR1A p.Glu303del and a homozygous frameshift variant, respectively (Clark et al., 2016; Reichert et al., 2017) .
TorsinA is a member of the AAA + ATPase superfamily of proteins, located within the lumen of the endoplasmic reticulum and nuclear envelope. Although it is diffusely located, predominantly in the peripheral endoplasmic reticulum lumen, the torsinA p.Glu303del concentrates in the nuclear envelope and is associated with defects in nuclear envelope morphology . To gain insight into the cellular properties of the torsinA p.Gly318Ser substitution, we tested the tendency to concentrate in the nuclear envelope; a hallmark of the p.Glu303del and p.Phe205Ile torsin1A mutants Calakos et al., 2010) . In transfected cells, the p.Gly318Ser mutant formed spheroid bodies and exhibited enhanced nuclear envelope localization compared with the wild-type torsin1A. The localization was similar to that previously reported for p.Glu303del and p.Phe205Ile torsin1A mutants, suggesting the pathogenic mechanism is similar for the novel mutant.
Mutations in genes encoding inner nuclear membrane proteins are associated with several disease conditions that typically manifest as tissue-specific disorders (Burke and Stewart, 2002) . Similar to DYT1 dystonia associated with p.Glu303del torsinA, these diseases may display low penetrance and variable expressivity (Bonne et al., 2000; Vytopil et al., 2002) . TOR1A mutations in the families presented in this study also display decreased penetrance, with carrier parents remaining clinically unaffected.
In conclusion, we report further expansion of molecular genetics and the phenotypic spectrum associated with mutation of TOR1A. We suggest that homozygous variants in TOR1A cause a severe arthrogryposis phenotype, including contractures of large and small joints, with developmental delay, progressive strabismus and infantile tremor. TOR1A mutation should be considered a strong candidate in cases harbouring this unique constellation of clinical features.
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